Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector
Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction
Company announces development of novel intranasal formulation with promising efficacy
New academic journal spotlights potential for rare cannabinoids to treat skin conditions
Dimethyltryptamine continues to demonstrate tremendous therapeutic potential
Canadian company set to focus clinical trials down under, announces regulatory update
Many distributors are choosing not to test their products for microbes, pesticides and heavy metals
Up to 37 per cent experienced positive side effects such as feeling active, energetic, "frisky" or productive
The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds
But whether or not the disruption helps with the substance's antidepressant properties still needs further research
The study also found that seven out of ten patients did not suffer from adverse effects
Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience
NFL players aren't allowed to participate in the research
But the results reinforce the view that laws based on blood-THC tests aren't supported by evidence
The study adds to a body of emerging research suggesting pot is effective in reducing opioid use
Substances helped lower people's anxiety and shame, but also lead to riskier sexual behaviours
Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa
The largest increase in drivers with moderate injuries was seen in men over 50
A recent study suggests the method could be used in roadside assessments of impaired driving from THC
Certain cannabinoids appear to block the virus from attaching to the 'doorway' of the cell
Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects
The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market
Currently treatments are largely insufficient, so care providers encourage more research despite stigma
Olorinab is a CB2 receptor agonist in a Phase 2 trial for IBS
And some terpenes have painkilling effects without interacting with cannabinoid receptors
Terpenes are only part of what gives some types of weed their unique smells and other related properties
The research casts doubt on currently used methods for detecting impairment
There are more than 3,800 studies on weed published this year already, surpassing a record set in 2020
Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics
The methods will be available as part of third-party client services
Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements
Cannabis and 'classical' psychedelics could act on similar receptors
While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases
But terpenes might be tempering the process
Several of the common smell-producing compounds in cannabis are associated with analgesic properties, and have attractive safety profiles
It’s the first federal grant to be awarded for psychedelic treatment research in 50 years
Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments
On average, unregulated bud tested had 10%-lower THC than advertised
A study linked self reports of being stoned with time and movement in young adults
The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say







































